Corcept Therapeutics Inc (CORT)
45.43
+0.39
(+0.87%)
USD |
NASDAQ |
Oct 04, 16:00
45.38
-0.05
(-0.11%)
After-Hours: 20:00
Corcept Therapeutics Shareholders Equity (Annual): 506.70M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 506.70M |
| December 31, 2022 | 501.84M |
| December 31, 2021 | 375.81M |
| December 31, 2020 | 523.34M |
| December 31, 2019 | 371.18M |
| December 31, 2018 | 275.88M |
| December 31, 2017 | 190.97M |
| December 31, 2016 | 41.38M |
| December 31, 2015 | 18.50M |
| December 31, 2014 | -3.388M |
| December 31, 2013 | 21.02M |
| December 31, 2012 | 61.78M |
| Date | Value |
|---|---|
| December 31, 2011 | 34.81M |
| December 31, 2010 | 21.24M |
| December 31, 2009 | 22.09M |
| December 31, 2008 | 16.91M |
| December 31, 2007 | 14.73M |
| December 31, 2006 | 6.36M |
| December 31, 2005 | 26.59M |
| December 31, 2004 | 45.95M |
| December 31, 2003 | -31.47M |
| December 31, 2002 | -21.94M |
| December 31, 2001 | 22.38M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
371.18M
Minimum
2019
523.34M
Maximum
2020
455.77M
Average
501.84M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Akebia Therapeutics Inc | -30.58M |
| Bioventus Inc | 173.59M |
| Alnylam Pharmaceuticals Inc | -220.64M |
| Catalyst Pharmaceuticals Inc | 387.88M |
| ADMA Biologics Inc | 135.21M |